20/10/2021 - General information
Patients with chronic kidney disease treated with bisphosphonates have a 15% higher risk of disease progression, although it is not linked to a higher rate of acute kidney injury, gastrointestinal events or hypocalcaemia. The study warns of the importance of assessing the stage of severity of CKD before prescribing bisphosphonates, as "They can worsen renal function and, in these cases, alternative treatments should be sought."
18/10/2021 - General information
These new grants are linked to the Spanish Government's Recovery, Transformation and Resilience Plan and are co-financed by the European Union's Next Generation funds. Four projects involving the IMIM will benefit. Four research projects led by or involving researchers from the Hospital del Mar Medical Research Institute (IMIM) will receive funding from the State Research Agency (Agència Estatal d'Investigació), as part of the aid promoted in Spanish and European plans linked to recovery from the COVID-19 pandemic. In total of, each project will receive just over 790,000 euros from these funds.
15/10/2021 - General information
From October 18 to 23, the PRBB and its centers invite you to participate in the open day of the Barcelona Biomedical Research Park and get inside the research they do. This time the format will be hybrid and will combine premieres, streaming activities and the first face-to-face event after the pandemic, a round table on the importance of the gender perspective in biomedical research. Throughout the week we will present a series of short videos from the different centers on Neuropharmacology, Cell Biology, Biobanks, Evolution and Cancer that will be released on the PRBB Youtube channel. On the same channel we will make live visits to laboratories investigating the effects of air pollution, synthetic biology and CRISPR, blood stem cells, proteomics and 3D microscopy. And fromInstagram we will broadcast live interviews between three researchers / as and three Instagramers, specialized in science.
05/10/2021 - General information
With this new group, the Carlos III Health Institute's Networked Biomedical Research Centre aims to unite Spain's scientific excellence in this field to enable better funding in emerging diseases, such as COVID-19, and other research areas, including antimicrobial resistance and HIV-AIDS, in which Hospital del Mar and IMIM researchers have a great deal of experience. The Infectious Pathology and Antimicrobial Research Group (IPAR) at the Hospital de Mar Medical Research Institute (IMIM) will form part of the new CIBER on Infectious Diseases. The purpose of this new group is to promote research in this field in Spain by offering new structural funding tools.
Més informació "Hospital del Mar and IMIM to participate in the new CIBER on infectious diseases"
13/09/2021 - General information
The editorial team of this prestigious publication, the third most important in respiratory medicine according to impact factor, has invited the consultant physician from the Pneumology Department and researcher at the Hospital del Mar Medical Research Institute, to collaborate with them. Dr. Esther Barreiro has joined the editorial team at the European Respiratory Society, as Associate Editor of the European Respiratory Journal (ERJ). Her role involves assisting the journal's senior editors to select potentially interesting manuscripts for publication, as well as inviting reviewers and providing advice on publication decisions. She will also write editorials for publication.
09/09/2021 - General information
A study lead by researchers from the Hospital del Mar Medical Research Institute (IMIM) and the Centre for Cellular and Molecular Biology of the Council Of Scientific And Industrial Research (CSIR) published in the Science Advances journal, shows for the first time how cholesterol can interfere with the function of a important receptor present in brain cells - the serotonin receptor. This finding is of great importance, as it allows to devise new ways to modulate those receptors, which in the future could lead to the development of new drugs to treat diseases of the central nervous system. Cholesterol is an essential component of the neuron membrane. Multiple proteins reside within those membranes, including GPCRs (G-protein coupled receptors). GPCRs are a large receptor family, encompassing serotonin receptors, which act as cellular receptors, detecting outside signals and transmitting towards the cell. Because of this, GPCRs are crucial for correct communications between cells.
10/08/2021 - General information
The Director of the Healthcare and Medical Area, head of the General and Digestive Surgery Service and co-coordinator of the Clinical and Translational Research Group on Colorectal Neoplasms at the Hospital del Mar Medical Research Institute, is one of the top specialists among Catalan digestive surgeons. Dr. Miguel Pera is one of the ten most outstanding digestive surgeons in Catalonia, according to the ranking published by the Institute of Governance and Economics Coordinates. This institution has published its TOP 100 ranking of the best doctors practising in Catalan hospitals, both public and private. The list has been compiled on the basis of their healthcare, research and teaching activities.
28/07/2021 - General information
On July 19 the Barcelona Biomedical Research Park (PRBB) launched a new science outreach product, "La mare de la ciència", a podcast in Catalan where you can "listen to science" done at the Park. During the second half of July the six episodes that make up the first season will be released. Today, July 28th, the podcast of Toni Celià-Terrassa, group leader of the Cancer Stem Cells and Metastasis Dynamics group at the IMIM, will be launched and will help us to decipher metastasis. This is a narrative podcast in short format, where Marta Vila, from the PRBB's communication department, leads us through the research and stories of six researchers from the Park's centres. A very personal and close look to the science that is done in the PRBB and the people behind it.
Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23. The Hospital del Mar Institute for Medical Research (IMIM) will once again be Olympic. Two of the Anti-Doping Laboratory of Catalonia professionals at IMIM will work at the Olympic Games Laboratory in Tokyo, which starts this July 23. Sergi Coll and Lídia Requena will travel to Tokyo to work there until August 10. Sergi Coll specializes in detecting anabolic steroids, and Lídia Requena specializes in detecting hormones (erythropoietin, growth hormone ...) and blood transfusions.
Dr Joan Albanell, head of the Medical Oncology Department at Hospital del Mar and director of the Cancer Research Programme at the Hospital del Mar Medical Research Institute, is one of the authors of the first article to come out of this study, in which more than sixty hospitals from eleven European countries are taking part. The work, published in the prestigious journal Cancer Discovery, is an important step in understanding the molecular changes that lead to metastasis in breast cancer.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
